Bain Capital Life Sciences Investors, LLC

Q3 2025 13F Holdings

  • Location
    boston, MA
  • Num holdings

    21

  • Value ($000)

    $1,506,676

  • Date Filed
    11/14/2025
  • Form type
    13F-HR
  • CIK
    0001703031
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q3 2025 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
---

HEARTFLOW INC

COM
42238D107
$419.00M
28 %

12,448,158

---

NEWAMSTERDAM PHARMA COMPANY

ORDINARY SHARES
N62509109
$304.85M
20 %

10,719,110

C
CDTX

CIDARA THERAPEUTICS INC

COM NEW
171757206
$289.29M
19 %

3,020,990

---

PHARVARIS N V

COM
N69605108
$79.37M
5 %

3,181,275

O
OLMA

OLEMA PHARMACEUTICALS INC

COM
68062P106
$67.00M
4 %

6,843,954

Y
YB4P

SAVARA INC

COM
805111101
$62.83M
4 %

17,600,621

D
DNTH

DIANTHUS THERAPEUTICS INC

COM
252828108
$51.78M
3 %

1,315,892

---

SOLID BIOSCIENCES INC

COM NEW
83422E204
$48.81M
3 %

7,911,669

---

UPSTREAM BIO INC

COM
91678A107
$45.89M
3 %

2,439,538

R
RPID

RAPID MICRO BIOSYSTEMS INC

CLASS A COM
75340L104
$28.17M
2 %

8,434,560

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 21